Loading...

Company

Corporate Information

Company Name Quantum Flowers & Foods Co., Ltd.(QFF)
President, CEO & CTO Norio KIKUCHI
Director CFO Shuichi URUNO
Outside Directors Tetsuya TAKAO
Founded July 2018
Paid-in Capital JPY 172,780,000
Headquarters & Facilities
QFF Head Office / Mito Office
#2-101 Le Reve Migawa, 2563-77 Migawa, Mito, Ibaraki, 310-0913, Japan
QFF Tokai Lab
Quantum Beam Research Center 2 Room 101, AYA’S LABORATORY 162-1 Shirakata, Tokai-mura, Naka-gun, Ibaraki, 319-1106, Japan
QFF Tokyo Branch Office
NEXs Tokyo, New Tokyo Bldg. 4F, 3-3-1 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan
Business – Development and licensing of quantum agriculture – Neutron beam breeding – Quantum biotechnology – Intellectual property management

Mission

We develop diverse genetic resources to solve the world’s food problems.
Quantum Flowers & Foods (QFF) is the world’s first deep-tech company to implement “quantum biotechnology” using neutron beams in society. Our goal is to develop a sustainable bio-agri-tech business model to address various global issues such as the worsening food production environment due to significant global environmental changes and carbon neutrality, both domestically and internationally, thereby pioneering the future of the SDGs society.

Team Members

Norio KIKUCHI

CEO & CTO Founder Ph.D in Physics KEK Cooperative Researcher

Dr Kikuchi is currently the Chief Executive Officer (CEO) and the Chief Technology Officer (CTO) at QFF. He is the Chairman of the Board of Directors of the Quantum Agriculture Association. He was the Chief Executive Officer (CEO) of the Tier 1 heavy electrical manufacturing company, Hitachi Ltd. During this time, Dr Kikuchi won the Good Design Monozukuri Design Award. Not only was his company selected as one of the 300 Small and Medium-sized Enterprises, it was selected as the regional future innovation company. He worked on natural energy development in emerging countries as a part of JICA’s ODA projects, aiming for a sustainable Earth through the power of quantum biotechnology. He graduated from Oxford University with a Ph.D in Theoretical Physics. His biophysics paper has 710 total citations with a H-index of 7.

Syuichi URUNO

Director CFO Founder

Mr Uruno currently leads the financial aspect of the business as the Chief Financial Officer (CFO) at QFF and he is the Representative Director of Tarp State Consulting. He worked as a Representative Director of the STC Group and has assisted various companies with their management issues through finance, taxation and accounting. He was the Director of the Japan Association of Management Accounting Professionals. He also participated in Akatsuka Station City Planning and has established the Mito Planning Organization, LLC. Mr Uruno graduated from the University of Tsubuku in Social Engineering. He has completed the Advanced Management Accounting Specialist (EMBA) program at Kyoto University Graduate School of Business Administration. He is certified as a Senior Management Accounting Specialist. Mr Uruno is qualified as a Senior Expert in M&A, Japan Investors Securities Co.

Tetsuya TAKAO

Outside Director Ph.D in Medicine

Dr Takao is the Chairman of the Board of Directors at the Epsilon Medical Corporation and the Chairman of Ibaraki Prefecture Association of Psychiatric Clinics that operates several psychiatric clinics, employment centers for the disabled, nursing home stations and industrial health care services. He is the Director of Mito Medical Association and is the President of the Mito Mental Clinic. Dr Takao is a certified psychiatrist, industrial physician and mental health physician. He graduated with a Ph.D in Medicine from Tsukuba University.

Akira TAKAGI

Advisor [ Financial strategy ]

At QFF, Mr Takagi provides general business support focusing on financial strategies, M&A, fundraising and IPO. He is currently the Director of Takagi Certified Public Accountants Office, Vice Chairman of the Committee for Supporting Small and Medium Enterprises of the Japanese Institute of Certified Public Accountants. He is also the Outside Auditor of iMobile, Inc. He served as an Outside Director for several listed and unlisted companies as well as an advisor to financial institutions, business companies and venture companies.

Dr. May Sweet

Research scientist at QFF [ Quantum beam technology ] Ph.D in Biophysics KEK Cooperative Researcher

Dr. May Sweet is a quantum biotech researcher at QFF, working towards addressing global Sustainable Development Goals (SDGs) through computer simulations, experiments and AI data science. She collaborates with KEK on innovative quantum beams technology (neutron beam) for irradiation research. Originally from Myanmar, she graduated a Ph.D in Biophysics from Gifu University, Japan. She specializes in biomolecular motors, biophysics, nanotechnology and she completed her Masters in Particle Physics. Her high-impact research publications, including a notable one in “Nature (Scientific Reports) ”.

JAPAN’S GAME CHANGING
QUANTUM TECHNOLOGY

New Quantum Biotech Business